VOYA INVESTMENT MANAGEMENT LLC
Position in TBPH — Theravance Biopharma, Inc.
CIK 1068837
ATLANTA, GA
Position in TBPH
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$316,225
+$188,355 QoQ
Shares Held
19,484
+68.1% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,260,471,504 across 174 Biotechnology names. TBPH ranks #108 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
349,912 | $270,356,007 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
527,047 | $235,347,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,488 | $49,130,223 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
454,383 | $47,891,967 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
656,129 | $41,139,286 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
538,980 | $40,024,653 | |
| 7 | INSM |
INSMED Inc
|
243,706 | $39,850,804 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
725,409 | $35,661,105 |
All Filings in TBPH
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $316,225 | 19,484 | Shares | Defined | 2026-05-12 | |
| 2025-06-30 | $127,870 | 11,593 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $103,525 | 11,593 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $123,289 | 13,102 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $112,058 | 13,903 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $143,159 | 16,882 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $161,137 | 17,964 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $270,164 | 24,036 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $228,902 | 26,524 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $274,523 | 26,524 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $281,546 | 25,949 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $291,147 | 25,949 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $263,122 | 25,949 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $222,341 | 24,541 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $391,348 | 40,936 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $455,237 | 41,198 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $157,094 | 21,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $304,934 | 21,001 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $441,162 | 21,615 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $355,488 | 20,005 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $250,502 | 16,943 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $355,633 | 16,943 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $551,982 | 23,885 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||